BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada.

Dr. Ashwin Rao brings more than two decades of extensive experience across business, academia and Wall Street. As Chief AI Officer and Chief AI Scientist at distributor and retail enterprises, he led ...

Bio-IT World Conference & Expo, the premier global event uniting more than 2,900 biopharma, biomedical research, healthcare, informatics and technology leaders, returns to Boston May 19-21, 2026 to ...

An engineer for New York Times Games has been trying to teach artificial intelligence to understand wordplay more like a ...

I use it extensively, and the countless pieces I’ve written about it at XDA are all the proof you need that I rely on it more ...

Picus Security explains why relying on LLM-generated attack scripts is risky and how an agentic approach maps real threat ...

If Europe wants to excel at tech and innovation, it needs to stop throttling the marketplace with regulations and taxes. Nor ...

Overall, moving my years of Notion data to Obsidian was about more than just switching tools; it was a transition from a ...

The deal, believed to be valued at $1 billion, will bring nonhuman identity access control of agents and machines to ...

As a data-driven analysis and decision-making tool, student portraits have gained significant attention in education ...

The rapid development of artificial intelligence technology has propelled the automated, humanized, and personalized learning ...

BELLEVUE, WA / ACCESS Newswire / December 2, 2025 / CoreStack today announced the full public release of Graphion™, a Cloud-Native and AI-Native Cloud-Native Application Protection Platform (CNAPP) ...